In a preclinical mouse model of breast cancer, angiopoietin-2 (Ang2) neutralizing antibody treatment significantly improved the vascular structure, partly due to the recruitment of mature pericytes (Desmin+) and reduced hypoxia [23]. The gene discussed is ANGPT2; the disease is breast cancer.